Progenra Inc. reports that it has discovered a new class of small-molecule PINK1 activators that restore function in mutant forms of the PINK1 kinase, a key mitochondrial regulator whose dysfunction ...

In a major scientific advance, Progenra Inc. has announced the discovery of a novel class of small-molecule drugs designed to restore the function of mutant forms of ...